High concentration of deoxycholic acid abrogates in vitro transformation of IEC6 intestinal cells by azoxymethane

Journal of Experimental and Clinical Cancer Research

Volumn 24, Issue 4, 2005, Pages 625-631

  Sasaki, T ^a   Shimura, H ^b   Sasahira, T ^a   Fujii, K ^b   Kuniyasu, Hiroki ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Apoptosis; Azoxymethane; Colon cancer; Deoxycholic acid; IEC6; In vitro transformation

Indexed keywords

AGAR; AZOXYMETHANE; BETA CATENIN; CYTOCHROME P450 2E1; DEOXYCHOLIC ACID; PROTEIN BAX; PROTEIN BCL 2; PROTEIN MLH1; STRESS ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL GROWTH; CELL LINE; CELL STRAIN IEC; CELL TRANSFORMATION; COLON CANCER; COLONY FORMATION; COMET ASSAY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA DAMAGE; ENZYME SYNTHESIS; GENOTOXICITY; IN VITRO STUDY; INTESTINE CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; AZOXYMETHANE; CARCINOGENS; CELL LINE; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; COMET ASSAY; CYTOCHROME P-450 CYP2E1; DEOXYCHOLIC ACID; MICE; MICE, NUDE; NEOPLASMS, EXPERIMENTAL; RATS;

EID: 31344448494     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Shike M., Nawer S.J., Greenwald P.H., Bloch A., Hill M.J., Swaroop S.V.: Primary prevention of colorectal cancer. The WHO Collaborating Centre for the Prevention of Colorectal Cancer. Bull. World Health Organ. 68:377-385, 1990.
2. Miller A.B., Howe G.R., Jain M., Craib K.J., Harrison L.: Food items and food groups as risk factors in a case-control study of diet and colo-rectal cancer. Int. J. Cancer 32:155-161, 1983.
3. Giovannucci E., Willett W.C.: Dietary factors and risk of colon cancer. Ann. Med. 26:443-452, 1994.
4. Reddy B.S., Wynder E.L.: Metabolic epidemiology of colon cancer. Fecal bile acids and neutral sterols in colon cancer patients and patients with adenomatous polyps. Cancer 39:2533-2539, 1977.
5. Bayerdorffer E., Mannes G.A., Richter W.O., Ochsenkuhn T., Wiebecke B., Kopeke W., Paumgartner G.: Increased serum deoxycholic acid levels in men with colorectal adenomas. Gastroenterology 104:145-151, 1993.
6. Reddy B.S., Watanabe K., Weisburger J.H., Wynder E.L.: Promoting effect of bile acids in colon carcinogenesis in germ-free and conventional F344 rats. Cancer Res. 37:3238-3242, 1977.
7. Sutherland L.A., Bird R.P.: The effect of chenodeoxycholic acid on the development of aberrant crypt foci in the rat colon. Cancer Lett. 76:101-107, 1994.
8. Narisawa T., Magadia N.B., Weisburger J.H., Wynder E.L.: Promoting effect of bile acids on colon carcinogenesis after intrarectal instillation of N-methyl-N'-nitro-N-nitrosoguanidine in rats. J. Natl. Cancer Inst. 53:1093-1097, 1974.
9. Bartram H.P., Scheppach W., Schmid H., Hofmann A., Dusel G., Richter F., Richter A., Kasper H.: Proliferation of human colonic mucosa as an intermediate biomarker of carcinogenesis: effects of butyrate, deoxycholate, calcium, ammonia, and pH. Cancer Res. 53:3283-3288, 1993.
10. Peiffer L.P., Peters D.J., McGarrity T.J.: Differential effects of deoxycholic acid on proliferation of neoplastic and differentiated colonocytes in vitro. Dig. Dis. Sci. 42:2234-2240, 1997.
11. Milovic V., Stein J., Odera G., Gilani S., Murphy G.M.: Low-dose deoxycholic acid stimulates putrescine uptake in colon cancer cells (Caco-2). Cancer Lett. 154:195-200, 2000.
12. Martinez J.D., Stratagoules E.D., LaRue J.M., Powell A.A., Gause P.R., Craven M.T., Payne C.M., Powell M.B., Gerner E.W., Earnest D.L.: Different bile acids exhibit distinct biological effects: the tumor promoter deoxycholic acid induces apoptosis and the chemopreventive agent ursodeoxycholic acid inhibits cell proliferation. Nutr. Cancer 31:111-118, 1998.
13. Schlottman K., Wachs F.P., Krieg R.C., Kullmann F., Scholmerich J., Rogler G.: Characterization of bile salt-induced apoptosis in colon cancer cell lines. Cancer Res. 60:4270-4276, 2000.
14. Qiao D., Stratagouleas E.D., Martinez J.D.: Activation and role of mitogen-activated protein kinases in deoxycholic acid-induced apoptosis. Carcinogenesis 22:35-41, 2001.
15. Milovic V., Teller I.C., Faust D., Caspary W.F., Stein J.: Effects of deoxycholate on human colon cancer cells: apoptosis or proliferation. Eur. J. Clin. Invest. 32:29-34, 2002.
16. Hague A., Elder D.J., Hicks D.J., Paraskeva C.: Apoptosis in colorectal tumour cells: induction by the short chain fatty acids butyrate, propionate and acetate and by the bile salt deoxycholate. Int. J. Cancer 60:400-406, 1995.
17. Quaroni A., Isselbacher K.J., Ruoslahti E.: Fibronectin synthesis by epithelial crypt cells of rat small intestine. Proc. Natl. Acad. Sci. USA. 75: 5548-5552 1978.
18. Conteas C.N., Majumdar A.P.: The effects of gastrin, epidermal growth factor, and somatostatin on DNA synthesis in a small intestinal crypt cell line (IEC-6). Proc. Soc. Exp. Biol. Med. 184: 307-311, 1987.
19. Alley M.C., Scudiero D.A., Monks A., Hursey M.L., Czerwinski M.J., Fine D.L., Abbott B.J., Mayo J.G., Shoemaker R.H., Boyd M.R.: Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res. 48:589-601, 1988.
20. Reddy B.S., Wynder E.L.: Large-bowel carcinogenesis: fecal constituents of populations with diverse incidence rates of colon cancer. Natl. Cancer Inst. 50:1437-1442, 1973.
21. Kishida T., Taguchi F., Feng L., Tatsuguchi A., Sato J., Fujimori S., Tachikawa H., Tamagawa Y., Yoshida Y., Kobayashi M.: Analysis of bile acids in colon residual liquid or fecal material in patients with colorectal neoplasia and control subjects. J. Gastroenterol. 32:306-311, 1997.
22. Morvay K., Szentleleki K., Torok G., Pinter A., Borzsonyi M., Nawroth R.: Effect of change of fecal bile acid excretion achieved by operative procedures on 1,2-dimethylhydrazine-induced colon cancer in rats. Dis. Colon. Rectum 32:860-863, 1989.
23. Sohn O.S., Ishizaki H., Yang C.S., Fiala E.S.: Metabolism of azoxymethane, methylazoxymethanol and N-nitrosodimethylamine by cytochrome P450IIE1. Carcinogenesis 12:127-131, 1991.
24. Feinberg A., Zedeck M.S.: Production of a highly reactive alkylating agent from the organospecific carcinogen methylazoxymethanol by alcohol dehydrogenase. Cancer Res. 40:4446-4450, 1980.
25. Sohn O.S., Fiala E.S., Requeijo S.P., Weisburger J.H., Gonzalez F. J.: Differential effects of CYP2E1 status on the metabolic activation of the colon carcinogens azoxymethane and methylazoxymethanol. Cancer Res. 61:8435-8440, 2001.
26. Pongracz J., Clark P., Neoptolemos J.P., Lord J.M.: Expression of protein kinase C isoenzymes in colorectal cancer tissue and their differential activation by different bile acids. Int. J. Cancer 61:35-39, 1995.
27. Qiao D., Im E., Qi W., Martinez J.D.: Activator protein-1 and CCAAT/enhancer-binding protein mediated GADD153 expression is involved in deoxycholic acid-induced apoptosis. Biochim. Biophys. Acta. 1583:108-116, 2002.